Skip to main content
Premium Trial:

Request an Annual Quote

Veritas Bio Gets European Patent on Delivery Technology

Premium

Veritas Bio said this week that the European Patent Office has granted the company a patent covering its nucleic acid-delivery technology.

The patent, granted on patent application No. 07873598.21401, is entitled "In Vivo Delivery of Nucleic Acids," and covers the transfection of nucleic acids into skin or muscle cells. A US patent application on the technology was recently issued a notice of allowance.

As reported by Gene Silencing News, Vertias was established by the co-founders of defunct expressed RNAi drug firm Nucleonics as a holding company for the delivery technology while they look for parties interested in licensing the intellectual property (GSN 4/18/2013).

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.